15.12.2012 Views

EU Competition Law Update - Arnold & Porter LLP

EU Competition Law Update - Arnold & Porter LLP

EU Competition Law Update - Arnold & Porter LLP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>EU</strong> <strong>Competition</strong> <strong>Law</strong> <strong>Update</strong><br />

11 July 2012<br />

<strong>Arnold</strong> & <strong>Porter</strong> (Brussels) <strong>LLP</strong> is a limited liability partnership organized under the laws of the State of New York that is regulated<br />

by the Brussels Bar. It is an affiliate of <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong>, a limited liability partnership organized under the laws of the District<br />

of Columbia, which does not itself practice in Brussels.


<strong>Arnold</strong> & <strong>Porter</strong>’s <strong>EU</strong> <strong>Competition</strong> <strong>Law</strong> <strong>Update</strong><br />

Seminar/Webinar<br />

11 July 2012<br />

4:00 p.m. – 5:00 p.m. CET<br />

60 minutes<br />

Table of Contents<br />

Agenda ..................................................................................Tab 1<br />

Presentation Slides ...............................................................Tab 2<br />

Moderator/Speaker Biographies............................................Tab 3<br />

Marleen Van Kerckhove, Silvio Cappellari, Axel Gutermuth<br />

Practice Overview .................................................................Tab 4<br />

<strong>EU</strong> <strong>Competition</strong> <strong>Law</strong> Practice


Tab 1: Agenda


<strong>Arnold</strong> & <strong>Porter</strong>’s <strong>EU</strong> <strong>Competition</strong> <strong>Law</strong> <strong>Update</strong><br />

Seminar/Webinar<br />

11 July 2012<br />

4:00 p.m. – 5:00 p.m. CET<br />

60 minutes<br />

Agenda<br />

I. Introduction............................................................................4:00 – 4:05 p.m.<br />

Marleen Van Kerckhove, Antitrust/<strong>Competition</strong> Practice, <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong><br />

II. Presentation and Discussion .................................................4:05 – 4:50 p.m.<br />

Speakers:<br />

Marleen Van Kerckhove, Antitrust/<strong>Competition</strong> Practice, <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong><br />

Silvio Cappellari, Antitrust/<strong>Competition</strong> Practice, <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong><br />

Axel Gutermuth, Antitrust/<strong>Competition</strong> Practice, <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong><br />

III. Questions and Answers.........................................................4:50 – 5:00 p.m.<br />

Attending this webinar qualifies you for one accredited CPD hour - Ref 2616/ARPO.<br />

CLE is pending.


Tab 2: Presentation Slides


Agenda<br />

� Cartel enforcement<br />

Webinar:<br />

<strong>EU</strong> C<strong>Competition</strong> titi L<strong>Law</strong> U<strong>Update</strong> d t<br />

Marleen Van Kerckhove<br />

Silvio Cappellari<br />

Axel Gutermuth<br />

11 July 2012<br />

– Substance – Dow/DuPont (GC) and Window Mountings (EC)<br />

– Procedure – new Best Practices, “Manual of Procedure” and dawn raid litigation<br />

– Private enforcement – disclosure issues<br />

� Mergers<br />

– Trends: Policy and Statistics<br />

– Interesting cases<br />

� Abuse of dominance<br />

– Commission activity<br />

– Court judgments: Post Danmark, Microsoft, Tomra, Telefónica<br />

� Q&A<br />

2


Overview<br />

� Substance<br />

Cartel Enforcement<br />

– GC: DuPont and Dow => liability of JV parents<br />

– Statistics on GC proceedings<br />

– EC: Window Mountings => fines<br />

� Procedure<br />

– Reform of the EC’s procedural framework<br />

– EC’s EC s “Manual Manual of Procedure Procedure”<br />

– Litigation on dawn raids (AG Bot in E.On)<br />

� Private enforcement – disclosure issues<br />

– Aftermath of Pfleiderer<br />

– Disclosure under Regulation no. 1049/2001<br />

4


Substance<br />

� GC: Dow and DuPont (Chloroprene Rubber), 2 February 2012<br />

– Court confirmed parent liability for 50/50 JV due to “economic, organizational and<br />

legal links”<br />

– Need to prove ability to exercise decisive influence and actual exercise of such<br />

influence<br />

• Ability I: parent representatives in Member Committee, which had broad approval rights<br />

on strategic issues (appointment/dismissal of board and management members,<br />

approval of business and strategic plans ...) )<br />

• Ability II: approval of JV creation by the EC, which had found joint control<br />

• Actual exercise: decisions by the Member Committee, inter alia, (i) to appoint top<br />

managers; (ii) to close a production plant in the UK; and (iii) to conduct an internal<br />

audit into potential cartel participation<br />

Substance (cont’d)<br />

� GC: Dow and DuPont (cont’d)<br />

– Counter-arguments of the parent companies rejected<br />

• No knowledge of the cartel => irrelevant<br />

• Full-function character of the JV<br />

=> economic autonomy does not necessarily translate into strategic autonomy<br />

• Only “negative control”<br />

=> veto rights sufficient, power to impose decisions not necessary<br />

• Concept of “single economic entity” contradicts case-law on applicability of Article 101<br />

TF<strong>EU</strong> tto contractual t t lrelationship l ti hi bbetween t parents t and d JV<br />

=> no legitimate expectation that previous EC approach will be maintained<br />

– Conclusions<br />

• Confirmation of GC’s and EC’s tough stance on parent liability also for JVs<br />

• Important (though not surprising) clarifications on full functionality and negative control<br />

• Always fact-specific analysis (Industrial Bags, 6 March 2012 – no liability of JV parents<br />

due to insufficient factual evidence presented by the EC) 6<br />

5


Substance (cont’d)<br />

� Some statistics on GC proceedings (3/2011 – 3/2012)<br />

– 75 rulings concerning 13 EC decisions<br />

• 40 x EC decision upheld, 27 partial annulments, 8 total annulments<br />

• Reduction of total fines from <strong>EU</strong>R 3.6 billion to <strong>EU</strong>R 3.0 billion<br />

– Successful arguments<br />

• Wrong/insufficient analysis of the facts<br />

=> 23 successful claims (14 relating to duration)<br />

• Incorrect application of the Fining Guidelines<br />

=> > 14 successful claims (in particular cooperation and unequal treatment)<br />

• Parent liability<br />

=> 5 successful claims<br />

• General issues<br />

=> 5 successful claims (length of proceedings, time bar, no exercise of full jurisdiction)<br />

� CJ<strong>EU</strong> proceedings: 9 rulings concerning 4 EC decisions<br />

– 7 x GC ruling upheld, 2 annulments<br />

Substance (cont’d)<br />

� EC: Window Mountings, 28 March 2012<br />

– Decision more than 4.5 years after dawn raids<br />

– Total fines of <strong>EU</strong>R 86 million imposed on 9 companies<br />

– Exceptional application of point 37 of the 2006 Fining Guidelines as most cartel<br />

participants were single-product firms => significant fine reductions<br />

“Although these Guidelines present the general methodology for the setting of<br />

fines, the particularities of a given case ... may justify departing from such<br />

methodology.” th d l ”<br />

– Yet another example of EC’s increased flexibility on fines<br />

– EC stressed fact-specific nature of the decision – but potentially far-reaching<br />

implications<br />

7<br />

8


Substance (cont’d)<br />

� Other EC decisions<br />

– Freight Forwarders, 28 March 2012<br />

• Decision 4.5 years after dawn raids<br />

• Total fines of <strong>EU</strong>R 169 million imposed on 14 companies<br />

• Follow-up to Air Cargo case – but apparently different approach to single and<br />

continuous complex infringement (4 separate cartels)<br />

– Water Management, 27 June 2012<br />

• Decision 3.5 years after dawn raids – even though only 3 companies involved<br />

• Total fines of <strong>EU</strong>R 13.7 million imposed on two companies<br />

• Sixth settlement case<br />

– Mitsubishi and Toshiba (GIS), 27 June 2012<br />

• Re-adoption of decision after GC annulment (unequal treatment due to different<br />

reference years)<br />

• Significant fine reductions – <strong>EU</strong>R 218.6 million => <strong>EU</strong>R 131.6 million<br />

Procedure<br />

� Reform of EC EC’s s procedural framework for antitrust investigations<br />

– Notice on Best Practices<br />

• State of play meetings at key points of the proceedings<br />

• Access to key documents already during investigative phase<br />

• Information in the SO about parameters for fine calculation<br />

– Extended mandate of the Hearing Officer<br />

• Supervision regarding effective exercise of rights of defence throughout the proceedings<br />

• In particular in charge of disputes about privilege issues and self-incrimination<br />

• Strengthened role in preparation and conduct of Oral Hearings<br />

– Best Practice Guidelines for the submission of economic evidence<br />

• Recommendations regarding content and presentation of economic analysis<br />

• Guidance on response to requests for quantitative data<br />

9<br />

10


Procedure (cont’d)<br />

� Publication of EC’s EC s “Manual Manual of Procedure Procedure”<br />

– EC’s internal guidelines on the handling of antitrust investigations published in<br />

March 2012<br />

– Triggered by the request of a lawyer under Regulation no. 1049/2001<br />

– 278 pages – 28 chapters, inter alia dealing with the handling of complaints, the<br />

treatment of cartel whistleblowers and the decision processes within the EC<br />

– Chapters on sector inquiries and fines/remedies still “under construction”;<br />

chapter on dawn raids kept out completely (“protection of the investigation”)<br />

Procedure (cont’d)<br />

� Litigation on dawn raids<br />

– AG Bot, opinion in E.On case, 21 June 2012<br />

• GC upheld EC decision imposing a fine of <strong>EU</strong>R 38 million on E.On for breaking of seal<br />

• Bot: GC did not fully exercise its jurisdiction but largely relied on the EC’s fine calculation<br />

• Necessary: proportionality analysis based on turnover data – fine must be proportionate to<br />

(i) the seriousness of the infringement (breaking the seal); and<br />

(ii) the fine that E.On would have incurred if found guilty of a cartel infringement<br />

• Also: fine must have sufficient deterrent effect if compared to the infringer’s financial means<br />

– May 2011: <strong>EU</strong>R 8 million fine for breaking of seal imposed on Suez Environment and<br />

Lyonnaise des Eaux<br />

– March 2012: fines of <strong>EU</strong>R 2.5 million imposed on two Czech companies for<br />

obstruction of a dawn raid inspection<br />

• Unblocking of e-mail account after it had been blocked by the EC<br />

• Diversion of incoming e-mails from a blocked account to a server<br />

11<br />

12


Private Enforcement – Disclosure<br />

� Aftermath of CJ<strong>EU</strong>’s CJ<strong>EU</strong> s landmark Pfleiderer ruling<br />

– Germany: Pfleiderer II, 18 January 2012<br />

• No access to leniency applications and supporting documentary evidence<br />

• Interest in effective leniency program prevails<br />

– UK: National Grid (GIS), 4 April 2012<br />

• No request for access to corporate statements; but documents at issue likely included<br />

leniency materials (or explanations on leniency materials)<br />

• Pfleiderer balancing test to be applied also to documents in the EC’s file<br />

• Focus on principles of legitimate expectations and proportionality<br />

• Legitimate expectations: no greater exposure of leniency applicant to follow-on claims<br />

• Proportionality: (i) information available from other sources?; (ii) relevance of the<br />

information to the private damage action<br />

• Result: disclosure of additional 32 paragraphs of the EC’s decision; very limited<br />

access to RFI responses; no access to SO responses 13<br />

Private Enforcement – Disclosure (cont’d)<br />

� Aftermath of Pfleiderer (cont’d)<br />

– Joint Resolution by the Heads of the <strong>EU</strong>’s 27 NCAs of 23 May 2012:<br />

The NCAs are “determined to defend the effectiveness of leniency programs in<br />

order to ensure a high level of anti-cartel enforcement.”<br />

“[L]eniency materials should be protected against disclosure to the extent<br />

necessary to ensure the effectiveness of leniency programs.”<br />

� <strong>EU</strong> legislation on private enforcement<br />

– EC “Roadmap” foresees legislative proposal still in 2012 – probably a directive<br />

– Topics:<br />

• Access to the case file/protection of leniency programs<br />

• Standing of indirect purchasers/passing-on defense<br />

• Ways to make NCA decisions legally binding throughout the <strong>EU</strong><br />

14


Private Enforcement – Disclosure (cont’d)<br />

� Disclosure under Regulation no. 1049/2001<br />

– GC: EnBW (GIS), 22 May 2012<br />

• EC: no access to case file due to “unreasonable burden” to check the individual documents for<br />

business secrets or other confidential information<br />

• GC: any exception to general access right to be interpreted and applied strictly – EC needs to<br />

assess all options to grant access “in a concrete, specific and detailed manner”<br />

– CJ<strong>EU</strong>: Édition Odile Jacob, 28 June 2012<br />

• EC had turned down access request by a complainant in merger proceedings<br />

• GC: EC needs to demonstrate “in a concrete and individual manner” that disclosure would<br />

run counter to protection of commercial interests and/or protection of the investigation<br />

• CJ<strong>EU</strong>: “general presumption” that disclosure of EC’s correspondence with merging parties<br />

and third parties would undermine both objectives<br />

• Same presumption for EC-internal documents if proceedings are pending or likely to be reopened<br />

• Relevance also for antitrust files?<br />

Mergers<br />

15


Statistics<br />

January 2012 - June 2012<br />

� Phase I decisions: 116, of which<br />

– 79 under the simplified procedure<br />

– 3 with commitments<br />

� Phase II decisions: 3, of which<br />

– 2 with commitments<br />

– 1 prohibition<br />

� Phase II proceedings initiated: 6<br />

� Appeals bro brought: ght 44, of which hich<br />

– 3 against a clearance decision (both with and without<br />

commitments, both by merging party and by third parties)<br />

– 1 against a prohibition decision<br />

Trends<br />

� Review certain aspects of merger control<br />

regime:<br />

– Capture (certain) non-controlling minority acquisitions<br />

– More streamlining between EC and national regimes<br />

� Simplification of the process:<br />

– Pre-notification contacts: short, , informal, , flexible (see (<br />

also priority issue below)<br />

– Simplified procedure: further streamline<br />

17<br />

18


Priority principle in merger assessments<br />

� Seagate/Samsung: 4 to 3<br />

– First EC contact on 3/14; notified and announced on 4/19<br />

– Unconditional clearance after Phase II<br />

� Western Digital/Viviti: 3 to 2<br />

– Announced on 3/7; first EC contact on 3/10; notified on 4/20<br />

– Conditional clearance after Phase II (on appeal)<br />

� Seagate/Samsung decision:<br />

– “competitive competitive conditions existing at the time of notification constitute<br />

the relevant framework”<br />

– “neither necessary nor appropriate to take into account future<br />

changes [...] resulting from subsequently notified transactions”<br />

– “legal certainty, transparency and objectivity”<br />

Dawn raids in merger investigation<br />

� Caterpillar/MWM (19 October 2011 – published in 2012):<br />

– Phase II investigation – closed without commitments<br />

– Inspections shortly after opening of Phase II re concerns over:<br />

• Lack of bidding data<br />

• Provision of misleading information<br />

• Early implementation<br />

– Art 11(3) letter sent to industry association (IESG) and certain of<br />

its members requiring the handing over or completion of share<br />

and/or d/ biddi bidding ddata t<br />

Note: in parallel, the EC started an Article 101 investigation into the<br />

issue, which according to unconfirmed press reports has since<br />

been closed<br />

19<br />

20


Parallel EC and national investigations<br />

� Hutchison 3G Austria/Orange Austria (pending)<br />

– Both mobile network operators in Austria – 4 to 3<br />

transaction<br />

– Prior to acquisition, Orange will sell YESS! customers<br />

to A1 Telekom Austria (but conditional on first deal<br />

closing)<br />

– Hutchison 3G Austria/Orange is before EC and<br />

Orange/A1 Telekom Austria is before Austrian<br />

competition authorities – both are currently in Phase II<br />

– Austria asked for referral back<br />

Foreclosure<br />

� Google/Motorola Mobility (“MM”) (13 February 2012):<br />

ttwo vertical ti l relationships l ti hi<br />

– Google’s Android mobile OS (share attributed to Google) and<br />

Motorola Mobility’s smart mobile devices<br />

– Motorola Mobility’s standard essential patents as key inputs into<br />

the smart mobile devices industry<br />

� Assessment OS – competitor foreclosure:<br />

– Ability to foreclose: Google’s ability to favour one or other<br />

Android partner p will not change g as result of merger g<br />

– Incentive to foreclose: doubtful that Google could capture more<br />

profits from favouring MM’s devices rather than having a large<br />

base for its search and advertising services<br />

– Effects: any foreclosure would have limited impact since most<br />

competing OEMs have alternatives to turn to<br />

21<br />

22


Foreclosure (cont’d)<br />

� Potential concerns re MM’s SEPs<br />

– Raising royalty levels<br />

– Forcing potential licensees into cross-licenses on terms they would not otherwise have agreed to<br />

– Excluding competitors from the market<br />

� Ability<br />

– Despite FRAND obligations, Google has some ability to seek or threaten injunctions; but only<br />

applies to non-licensees Apple and Microsoft where MM has already sought injunctions – hence,<br />

not merger specific<br />

� Incentive<br />

– MM’s current maximum per-unit royalty is non-merger specific and Google has limited incentives to<br />

raise that level (incl. FRAND)<br />

– Google internal documents show that aim of transaction is to protect Android ecosystem rather than<br />

impede competition competition, plus Google public commitment to FRAND (see letter); plus threat of counter-<br />

suits<br />

– None of Google’s internal documents provide evidence that Google would seek injunctions against<br />

its competitors with the aim of ultimately excluding them from the market<br />

� Effect: not merger specific<br />

Prohibition and market definition<br />

� Deutsche Börse/NYSE Euronext (1 February<br />

2012)<br />

– European financial derivatives traded on exchanges,<br />

i.e., exchange-traded derivatives<br />

– Not substitutable with “over-the-counter” trade<br />

derivatives<br />

– CCreating i near-monopoly l with i h hi high h bbarriers i to entry,<br />

less innovation and no off-setting efficiencies (see<br />

below)<br />

23<br />

24


Prohibition and efficiencies<br />

� Deutsche Börse/NYSE Euronext<br />

“It is very rare that we have concerns that prompt a prohibition<br />

decision. But this did happen in the Deutsche Börse/NYSE<br />

Euronext deal this year, where we found that the transaction<br />

would have created a de facto global monopoly on derivatives<br />

with European underlyings. In that case, we rejected the<br />

efficiency claims that money would be saved by the netting of<br />

margins, in part because there was no evidence that without<br />

competition these savings would be transmitted to the investors.<br />

So let me say something about efficiencies. We are accused of<br />

not taking productive efficiencies into account when we assess<br />

mergers. This is not true and efficiency claims are always<br />

carefully assessed when they are submitted.<br />

But we cannot accept efficiencies when their benefits are not<br />

transmitted to the economy in term of prices or innovation but<br />

are instead kept as private profits.” (Almunia, 22 June 2012)<br />

Commitments<br />

� Sony/Mubadala/BMI (19 April 2012) – music publishing<br />

– Issues identified in online licensing of copyright<br />

– Concern focused on online licensing of Anglo-American chart<br />

hits in the EEA as an indispensable part of any online platform<br />

offering (in partcular UK and Ireland)<br />

– Divestiture of global rights to four catalogues and recent and<br />

future works of 12 contemporary Anglo-American artists<br />

� Western Digital/Viviti (23 November 2011) – hard disk<br />

drives<br />

– Need to preserve competition as well as innovation; explicit<br />

obligation imposed that buyer of divested assets should have<br />

innovation capability<br />

25<br />

26


Commission activity<br />

� No decisions.<br />

Abuse of dominance<br />

� Samsung (January 2012), Motorola (April 2012): Cases opened re alleged<br />

failure to honor commitments made to the European Telecommunications<br />

Standards Institute (ETSI) by seeking and enforcing injunctions in various<br />

Member States’ courts against competing mobile device makers based on<br />

alleged infringements of certain of its patents which it had declared essential to<br />

implement European mobile telephony standards.<br />

� Thomson Reuters: Offered Article 9 commitments rejected after market test<br />

(March 2012), improved commitments offered in May 2012. Alleged abuse:<br />

preventing customers or competitors from translating Reuters Instrument Codes<br />

(RIC) to alternative identification codes of other data feed suppliers (“mapping”).<br />

� MathWorks (March 2012): Case opened re alleged refusal to provide<br />

competitors with end-user software licenses and interoperability information<br />

(similar to Microsoft case). Products concerned: commercial control systems.<br />

28


Post Danmark: Overview<br />

� Preliminary ruling, ECJ, 27 March 2012, case C-209/10 – Grand Chamber<br />

� Post Danmark had a monopoly for addressed letters and parcels under a certain<br />

weight and a universal service obligation in that regard<br />

� Relevant market : distribution of unaddressed mail in Denmark – liberalized, but<br />

Post Danmark dominant – same distribution network as for addressed mail<br />

� Competitor Forbruger-Kontakt active in distribution of unaddressed mail<br />

� Forbruger initially had contracts with three large Danish supermarket chains,<br />

which switched to Post Danmark in 2004<br />

� National authority found that Post Danmark had abused its dominant position on<br />

the market for delivery of unaddressed mail by charging Forburger’s former<br />

clients lower rates than its existing clients without justification<br />

� Post Danmark appealed in Denmark, Danish Supreme Court referred to ECJ<br />

Post Danmark: Predatory pricing (1)<br />

� AKZO test for predatory pricing (ECJ 27):<br />

– Prices below average variable costs: abusive<br />

– Prices below average total costs: abusive if they are part of a plan to eliminate a<br />

competitor<br />

� In this case:<br />

– Selective low prices (to clients of competitor)<br />

– For one customer (Coop), the resulting price level was lower than Post<br />

Danmark’s average total cost for the business of delivery of unaddressed mail,<br />

but higher than its average incremental costs (~ average variable costs)<br />

– An intention to foreclose rivals in the sense of AKZO has not been established<br />

29<br />

30


Post Danmark: Predatory pricing (2)<br />

� “[A] policy by which a dominant undertaking charges low prices to certain major<br />

customers of a competitor may not be considered to amount to an exclusionary<br />

abuse merely because the price that undertaking charges one of those<br />

customers is lower than the average total costs attributed to the activity<br />

concerned, but higher than the average incremental costs pertaining to that<br />

activity […]” (emphasis added)<br />

� “In order to assess the existence of anti-competitive effects in circumstances<br />

such as those of that case, it is necessary to consider whether that pricing<br />

policy, without objective justification, produces an actual or likely exclusionary<br />

effect, to the detriment of competition and, thereby, of consumers’ interests.”<br />

� Thus, a selective price cut for one customer leading to prices in the second<br />

AKZO category does not constitute an “automatic” predatory pricing abuse, but<br />

an abuse is not excluded.<br />

� Relevance of plan to foreclose?<br />

Post Danmark: Discrimination<br />

� Question for preliminary ruling explicitly asked for the existence of an<br />

exclusionary abuse (ECJ, 18)<br />

� ECJ, 30: “The presence of price discrimination […] cannot of itself suggest<br />

that there exists an exclusionary abuse.”<br />

� Reply: “[…] may not be considered to amount to an exclusionary abuse<br />

merely because” (emphasis added)<br />

�� Thus Thus, selective price cuts may constitute a discrimination abuse – but under<br />

what circumstances?<br />

31<br />

32


Microsoft: Overview<br />

� GC, 27 June 2012, case T-167/08<br />

� Application for annulment regarding the <strong>EU</strong>R 899 million periodic penalty payment<br />

imposed against Microsoft in 2008<br />

� Reason for penalty: Microsoft’s non-compliance with the 2004 Commission decision from<br />

June 2006 to October 2007 (16 months)<br />

– NB: Earlier penalty of <strong>EU</strong>R 280.5 million for period from December 2005 to June 2006<br />

� 2004 decision required Microsoft to make interoperability information available “on<br />

reasonable and non-discriminatory terms” (Article 5(a) of 2004 decision)<br />

– Interoperability between (i) Microsoft Windows PCs and (ii) work group server operating systems<br />

– Only specifications of protocols, not Microsoft’s source code<br />

� 2008 decision held that interoperability information was not offered on reasonable terms<br />

before October 2007<br />

� GC upheld the Commission’s decision, but reduced the fine to <strong>EU</strong>R 860 million because it<br />

found that the Commission had not correctly assessed the gravity of Microsoft’s conduct<br />

Microsoft: Two preliminary aspects<br />

� GC: Obligation g to apply ppy “reasonable terms” not too<br />

unspecific, can be the basis for a periodic penalty<br />

payment in case of non-compliance<br />

� GC: Dominant company must offer reasonable terms on<br />

its own initiative<br />

33<br />

34


Microsoft: Assessment of “reasonableness” –<br />

strategic value vs intrinsic value of information<br />

� Commission and GC: the remuneration must not reflect<br />

the “strategic value” of the information, but only the<br />

information’s “intrinsic value”<br />

� Strategic value = remuneration rates reflecting the value<br />

resulting from the mere ability to interoperate (GC, 142)<br />

� All Allowing i Microsoft Mi ft to t charge h strategic t t i value l “would “ ld in i<br />

effect allow [Microsoft] to transform the benefits of the<br />

abuse into remuneration for the grant of the license”.<br />

(GC, 142)<br />

Microsoft: Assessing the intrinsic value of<br />

interoperability information<br />

� Work Group Server Protocol Pricing Principles to determine intrinsic<br />

value (GC, 31):<br />

i. Protocols = Microsoft’s own creation (not taken from the public domain)?<br />

ii. Protocols = innovation (they must be novel and not obvious to persons skilled in<br />

the art, interpreted as under the European Patent Convention)?<br />

Commission: found that only a very small part of the protocols in question<br />

include innovative information; and<br />

iii. Market valuation of comparable technologies required, excluding the strategic<br />

value stemming from the dominant position of any such technologies.<br />

Commission: comparable technologies are offered remuneration-free by<br />

Microsoft and by other undertakings<br />

� GC endorsed this approach and its application by the Commission.<br />

35<br />

36


Microsoft: Some implications<br />

� Burden on dominant company p y to establish reasonable<br />

royalty rates – procedural safeguards do not help.<br />

� Assessment of intrinsic value practically possible?<br />

� No explicit guidance for situations where patented<br />

technology has to be licensed on reasonable terms –<br />

ddecision i i iis li limited it d to t Microsoft’s Mi ft’ “N “No PPatent t t agreement”. t”<br />

� Impact on FRAND licensing in the context of standard<br />

setting?<br />

Tomra: Overview<br />

� ECJ, 19 April 2012, C-549/10 P<br />

� Appeal against the dismissal, by the GC in September 2010, of an<br />

application for annulment against a March 2006 Commission<br />

decision fining various Tomra entities <strong>EU</strong>R 24 million<br />

� Dominant position on several national markets for reverse vending<br />

machines (very high market shares for Tomra: above 70% or<br />

event t 95%)<br />

� Abuse : exclusivity agreements, individualized quantity<br />

commitments and individualized retroactive rebate schemes<br />

(period 1998-2002)<br />

� ECJ dismissed application, upheld Commission decision 38<br />

37


Tomra: Interesting Points (1)<br />

� Confirmation that anti-competitive intent is not relevant for the finding of abuse,<br />

and an intention to compete on the merits is no defence – but intent is one<br />

factor that can be taken into account<br />

� Foreclosure of a “substantial” part of the market is sufficient for a finding of<br />

abuse – precise “market coverage” of behaviour does not need to be<br />

established (was approximately 40%)<br />

� ECJ 42: “[T]he foreclosure by a dominant undertaking of a substantial part of the<br />

market cannot be justified by showing that the contestable part of the market is<br />

still sufficient to accommodate a limited number of competitors.”<br />

– “Customers on the foreclosed part of the market should have the opportunity to benefit from<br />

whatever degree of competition is possible on the market.”<br />

– “Competitors should be able to compete on the merits for the entire market and not just a part of it.”<br />

– “It is not the role of the dominant undertaking to dictate how many viable competitors will be allowed<br />

to compete for the remaining contestable portion of demand.”<br />

Tomra: Interesting Points (2)<br />

� Retroactive (loyalty) rebate schemes: not necessary to make a price<br />

– cost comparison of the dominant company. Largely reliance on<br />

old case law.<br />

– ECJ, 79: “The loyalty mechanism was inherent in the supplier’s ability to drive out<br />

its competitors by means of the suction to itself of the contestable part of<br />

demand.” It “is not necessary to assess the actual effect of the rebates on<br />

competition given that it is sufficient to demonstrate that the conduct at issue is<br />

capable of having an effect on competition” competition (or tends to restrict competition<br />

–<br />

ECJ, 68, 72).<br />

� Commission’s 2009 Guidance Paper on exclusionary abuses<br />

mentioned, but found to be irrelevant for a decision adopted in 2006<br />

39<br />

40


Telefónica: Overview<br />

� GC, 29 March 2012, cases T-336/07 (Telefónica) and T-398/07 (Spain)<br />

� Application for annulment of a July 2007 Commission decision imposing a<br />

fine of <strong>EU</strong>R 152 million on Telefónica<br />

� Abuse: Margin squeeze (2001 to 2006) as between<br />

– prices offered by Telefónica to downstream competitors for wholesale broadband access to<br />

Telefónica’s network at a regional and national level and<br />

– Telefónica’s Telefónica s prices for retail broadband access (downstream market).<br />

� GC dismissed application, upheld Commission decision<br />

� Telefónica has lodged an appeal<br />

Telefónica: Interesting points (1)<br />

� Margin squeeze test does not have to be carried out on the basis of an<br />

optimal mix of available wholesale access products, which are offered in<br />

separate product markets.<br />

– Thus, available local loop wholesale access (no abuse) was not relevant for the assessment<br />

of abuse on the market for national and regional wholesale access<br />

� Confirmation that margin squeeze is a separate abuse (Deutsche Telekom).<br />

– Excessive pricing on upstream market not relevant<br />

– Predatory pricing on downstream market not relevant<br />

� Confirmation that dominance on downstream market is not required<br />

(TeliaSonera).<br />

41<br />

42


Telefónica: Interesting points (2)<br />

� Confirmation that margin squeeze should be assessed based on prices and<br />

costs of the dominant firm (as efficient competitor test) (Deutsche Telekom)<br />

– “Whether an undertaking in a dominant position would have been sufficiently efficient to offer<br />

its retail services to end users otherwise than at a loss if it had first been obligated to pay its<br />

own wholesale prices for the intermediary services.”<br />

� Confirmation that strategy of dominant company can also be relevant.<br />

� GC upholds Commission’s calculation of Telefónica’s costs under the<br />

discounted cash f flow method and the “period-by-period “ approach”. ”<br />

� Commission was right in holding that the margin squeeze probably<br />

reinforced the barriers to entry and expansion and that the competition<br />

would have probably been stronger in the retail market absent the abuse.<br />

Thank you!<br />

43


Tab 3: Moderator/Speaker<br />

Biographies


arnoldporter.com<br />

<strong>Arnold</strong> & <strong>Porter</strong> (Brussels) <strong>LLP</strong> is a limited liability partnership organized under the laws of the State of New York that is regulated by the Brussels Bar. It is an affiliate of <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong>, a limited liability partnership organized<br />

under the laws of the District of Columbia, which does not itself practice in Brussels.<br />

Marleen Van Kerckhove<br />

Partner<br />

Marleen Van Kerckhove heads up the firm's<br />

European competition practice and its Brussels<br />

office. Her practice encompasses advice and<br />

representation before <strong>EU</strong> and national antitrust<br />

agencies on merger control, abusive conduct,<br />

price fixing and other restrictive practices, as<br />

well as litigation before European courts. She<br />

has steered many transactions successfully through <strong>EU</strong> and national<br />

merger control reviews across various industry sectors.In addition, she<br />

has advised extensively on the application of <strong>EU</strong> competition law to<br />

the pharmaceutical sector, and on the interplay between antitrust and<br />

intellectual property law. Ms. Van Kerckhove is a frequent speaker at<br />

programs and conferences in Europe, Japan and North America.<br />

Representative Matters<br />

� General Electric and NBCU Universal in connection with the<br />

Comcast- NBCU joint venture.<br />

� General Electric in its acquisition of Dresser Inc. Clearance in<br />

the <strong>EU</strong> and in multiple jurisdictions world-wide.<br />

� Sanyo in its merger with Panasonic. Obtained clearance in the<br />

<strong>EU</strong>.<br />

� European Federation of Pharmaceutical Industries<br />

Associations (EFPIA) before the European Court of Justice and<br />

the General Court in its intervention supporting AstraZeneca in<br />

its appeal against the European Commission's decision finding<br />

an Article 82 infringement with respect to certain of its alleged<br />

regulatory and IP conduct.<br />

� Pfizer in its acquisition of certain animal health businesses<br />

from Schering-Plough. Clearance in the <strong>EU</strong>.<br />

� Finmeccanica in its acquisition of DRS Technologies.<br />

Clearance in multiple jurisdictions world-wide.<br />

� Major international company with respect to a global<br />

competition compliance audit.<br />

� SBC in its acquisition of AT&T. Obtained clearance in multiple<br />

jurisdictions world-wide.<br />

� Cisco in its acquisition of Scientific-Atlanta. Obtained clearance<br />

in the <strong>EU</strong>.<br />

Contact Information<br />

Marleen.VanKerckhove@<br />

aporter.com<br />

tel: +32 (0)2 290 7817<br />

fax: +32 (0)2 290 7899<br />

1, Rue du Marquis -<br />

Markiesstraat, 1<br />

B-1000 Brussels<br />

Practice Areas<br />

Antitrust/<strong>Competition</strong><br />

FDA and Healthcare<br />

Telecommunications,<br />

Internet, and Media<br />

Education<br />

LLM, London School of<br />

Economics, University of<br />

London, 1987<br />

Diploma European <strong>Law</strong>,<br />

University of Nancy, France,<br />

1983<br />

LLB, University of Leuven<br />

(KUL), Belgium, 1982<br />

Admissions<br />

Brussels, Belgium


� Boston Scientific in its acquisition of Guidant. Obtained clearance in the <strong>EU</strong> and multiple other<br />

jurisdictions world-wide.<br />

� Group of consumer electronics companies before the European Commission with respect to an<br />

Article 82 EC Treaty complaint regarding abusive licensing conduct.<br />

� Pfizer in its acquisition of Pharmacia. Obtained clearance in the <strong>EU</strong> and multiple other<br />

jurisdictions world-wide.<br />

� General Electric in its proposed acquisition of Honeywell, assisting both with the notification to the<br />

European Commission and the subsequent appeal to the Court of First Instance.<br />

� Pfizer in its acquisition of Warner-Lambert. Obtained clearance in the <strong>EU</strong> and multiple other<br />

jurisdictions world-wide.<br />

Rankings<br />

� Chambers Global 2012 for <strong>Competition</strong>/European <strong>Law</strong>: Belgium<br />

� PLC Which lawyer? 2012: Recommended for <strong>EU</strong> Life sciences: <strong>Competition</strong>/Anti-trust<br />

� PLC Which lawyer? 2012: Recommended for competition/anti-trust<br />

� PLC Which lawyer? 2012: Recommended for <strong>EU</strong> <strong>Competition</strong><br />

� PLC Which lawyer? 2011: Endorsed for <strong>Competition</strong>/anti-trust (Belgium), <strong>EU</strong> Life sciences:<br />

competition/anti-trust (European Union), and <strong>EU</strong> <strong>Competition</strong> (European Union)<br />

� Chambers Europe: Europe’s Leading <strong>Law</strong>yers for Business 2011 for <strong>Competition</strong>/European <strong>Law</strong><br />

� The Legal 500 EMEA 2011 for <strong>Competition</strong><br />

� The International Who's Who of <strong>Competition</strong> <strong>Law</strong>yers 2011<br />

� Chambers Global: The World's Leading <strong>Law</strong>yers for Business 2011 for <strong>Competition</strong>/European<br />

<strong>Law</strong><br />

� Euromoney's Guide to Women in Business <strong>Law</strong> 2010: included as an Expert in <strong>Competition</strong> and<br />

Antitrust<br />

� Global <strong>Competition</strong> Review's "Women in Antitrust" 2009<br />

Articles<br />

� Marleen Van Kerckhove, Asim Varma and Marco Ramondino "<strong>EU</strong> Regulatory Procedures In The<br />

Pharmaceutical Sector" <strong>Competition</strong> <strong>Law</strong>360 Jul. 2010<br />

� Asim Varma and Marleen Van Kerckhove "Getting The Deal Through: Pharmaceutical Antitrust -<br />

Overview" Global <strong>Competition</strong> Review 2010<br />

� Marleen Van Kerckhove and Asim Varma "Getting The Deal Through: Pharmaceutical Antitrust -<br />

Overview" Global <strong>Competition</strong> Review 2009<br />

Marleen Van Kerckhove<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 2


� Tim Frazer, Luc Gyselen, Marleen Van Kerckhove, Asim Varma and Barbara H. Wootton "Getting<br />

The Deal Through: Pharmaceutical Antitrust" Global <strong>Competition</strong> Review 2008<br />

� Deborah L. Feinstein, Marleen Van Kerckhove and Barbara H. Wootton "Merger remedies in the<br />

<strong>EU</strong> and US" Practical <strong>Law</strong> Company's Cross-border <strong>Competition</strong> Handbook, Volume 1, 2007/08<br />

� Marleen Van Kerckhove "Getting The Deal Through: Intellectual Property & Antitrust - European<br />

Union" Global <strong>Competition</strong> Review 2008<br />

� Marleen Van Kerckhove "<strong>EU</strong> Merger Control: Can You Be Compensated When Things Go<br />

Wrong?" The American <strong>Law</strong>yer October 2007<br />

� Marleen Van Kerckhove "The Application of Article 82 EC Treaty to The Pharmaceutical Sector -<br />

Some Recent EC Guidance" The European Antitrust Review. [Reproduced with permission from<br />

<strong>Law</strong> Business Research. This article was first published in the October 2005 Issue.] 2006<br />

� Marleen Van Kerckhove "Parallel Trade in Pharmaceutical Products Following the EJC's Bayer<br />

Judgment: Can a Case be Made Under Article 82 EC Treaty?" The European Antitrust Review,<br />

2005<br />

� Ian Kirby, Lincoln Tsang, Marleen Van Kerckhove and William W. Vodra "Parallel Trade in the <strong>EU</strong><br />

and US Pharmaceutical Markets" Global Counsel Life Sciences Handbook, 2005/2006<br />

� Ian Kirby, Marleen Van Kerckhove and William W. Vodra "Parallel Trade in the <strong>EU</strong> and US<br />

Pharmaceutical Markets" Global Counsel Life Sciences Handbook 2004/2005<br />

Presentations<br />

� Marleen Van Kerckhove "Life-Cycle Management & Settlement Strategies Post Sector Inquiry"<br />

18th Annual <strong>EU</strong> Pharmaceutical <strong>Law</strong> Forum, May 12, 2009<br />

� Marleen Van Kerckhove "Patent Misuse and Abuse in the US and Europe: the Case of<br />

Pharmaceuticals" ABA Section of Antitrust <strong>Law</strong>/GW <strong>Law</strong> School <strong>Competition</strong> <strong>Law</strong> Center,<br />

November 20, 2008<br />

� Marleen Van Kerckhove "4th Annual In-House Counsel Forum on Pharmaceutical Antitrust"<br />

American Conference Institute, May 20,.2008<br />

� Marleen Van Kerckhove "Recent Antitrust Developments for Pharmaceutical and Biotechnology<br />

Companies" BIO conference, 2008<br />

� Marleen Van Kerckhove "Lifecycle Management of Pharmaceutical Products" 17th Annual <strong>EU</strong><br />

Pharmaceutical <strong>Law</strong> Forum, May 8, 2008<br />

� Marleen Van Kerckhove "Abuse of Dominance - What is the Scope of This Remedy?"<br />

<strong>Competition</strong> <strong>Law</strong> & Policy Forum, Toronto, April 2006<br />

� Marleen Van Kerckhove "The Application of <strong>EU</strong> and US Antitrust <strong>Law</strong> to Pharma and Biotech<br />

Companies" IBC Life Sciences Conference, London, April 2006<br />

� Marleen Van Kerckhove "<strong>Competition</strong> <strong>Law</strong> and Parallel Trade" <strong>EU</strong> Pharmaceutical <strong>Law</strong> Forum,<br />

Brussels, May 2005<br />

� Marleen Van Kerckhove "Private Antitrust Enforcement in the EC and the US" IBA Annual<br />

Antitrust Conference, Fiesole, September 2004<br />

� Marleen Van Kerckhove "<strong>EU</strong> Merger Control" UCLA Mergers & Acquisitions, February 2004<br />

Advisories<br />

Marleen Van Kerckhove<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 3


� "First <strong>EU</strong> Judgment on Abusive Conduct Through Use of Regulatory Procedures in the<br />

Pharmaceutical Sector" Jul. 2010<br />

� "The EC Pharmaceutical Sector Inquiry: Getting Real" Jul. 2009<br />

� "New Notice Clarifies <strong>EU</strong> Commission's Approach to Remedies in Merger Cases" Oct. 2008<br />

� "Quota Schemes: The New Rules for Pharmaceutical Companies--The European Court rules on<br />

the Use of Quota Schemes by Dominant Pharmaceutical Companies" Sep. 2008<br />

� "Schneider Electric v Commission - The European Court of First Instance Breaks Ground In<br />

Relation To Damages In Merger Cases" Jul. 2007<br />

� "Tetra Laval/Sidel--The European Court of Justice Clarifies the Standard of Proof and the Role of<br />

Behavioural Commitments in Merger Cases" Feb. 2005<br />

� "Restrictions of Supply by an Allegedly Dominant Pharmaceutical Manufacturer--Do They Infringe<br />

<strong>EU</strong> Antitrust <strong>Law</strong>?" Oct. 2004<br />

� "Restrictions of Supply by an Allegedly Dominant Pharmaceutical Manufacturer" Oct. 2004<br />

� "New <strong>EU</strong> Regulation on Technology Transfer Agreements" Apr. 2004<br />

� "EC <strong>Competition</strong> Policy After 1 May 2004 Frequently Asked Questions" Apr. 2004<br />

� "The Impact of the Amendments to the EC Merger Regulation (ECMR)" Jan. 2004<br />

Marleen Van Kerckhove<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 4


arnoldporter.com<br />

Silvio Cappellari<br />

Partner<br />

<strong>Arnold</strong> & <strong>Porter</strong> (Brussels) <strong>LLP</strong> is a limited liability partnership organized under the laws of the State of New York that is regulated by the Brussels Bar. It is an affiliate of <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong>, a limited liability partnership organized<br />

under the laws of the District of Columbia, which does not itself practice in Brussels.<br />

Mr. Cappellari is a partner in the firm's antitrust<br />

and competition practice group. His practice<br />

focuses on a broad range of issues under<br />

European and German competition law.<br />

Mr. Cappellari has represented clients in highprofile<br />

merger control cases before the European Commission and the<br />

German Federal Cartel Office, including several second phase<br />

proceedings. He also has gained significant experience in international<br />

cartel cases, such as the recent investigations by the <strong>EU</strong> Commission<br />

concerning marine hoses, air cargo, subsea power cables and car<br />

components.<br />

In addition, Mr. Cappellari has a general antitrust counseling practice.<br />

He regularly advises clients on the compliance of joint ventures and<br />

other cooperation arrangements with Article 101 TF<strong>EU</strong>, as well as on<br />

questions of abusive conduct under Article 102 TF<strong>EU</strong>.<br />

Mr. Cappellari has gained significant experience, inter alia, in the<br />

energy, logistics, motor vehicles, pharmaceuticals, and media<br />

industries.<br />

Prior to joining the firm, Mr. Cappellari worked with other US law firms<br />

in Brussels and Washington, DC. He is fluent in German and Italian.<br />

Representative Matters<br />

� GE and NBCU in the creation of a joint venture with Comcast<br />

before the <strong>EU</strong> Commission<br />

� A major producer of car components in a cartel investigation<br />

under Article 101 TF<strong>EU</strong> before the <strong>EU</strong> Commission<br />

� A Japanese power cable manufacturer in a cartel investigation<br />

under Article 101 TF<strong>EU</strong> before the <strong>EU</strong> Commission<br />

� Cargolux, a leading global cargo airline, in a cartel investigation<br />

under Article101 TF<strong>EU</strong> before the <strong>EU</strong> Commission<br />

� A major Eastern European gas company in Article 102 TF<strong>EU</strong><br />

proceedings before the <strong>EU</strong> Commission<br />

� Siemens in its acquisitions of UGS Corporation and VA Tech<br />

AG before the <strong>EU</strong> Commission<br />

Contact Information<br />

Silvio.Cappellari@aporter.com<br />

tel: +32 (0)2 290 7815<br />

fax: +32 (0)2 290 7899<br />

1, Rue du Marquis -<br />

Markiesstraat, 1<br />

B-1000 Brussels<br />

Practice Areas<br />

Antitrust/<strong>Competition</strong><br />

Education<br />

LLM, Columbia <strong>Law</strong> School,<br />

1998<br />

German Bar Exam<br />

(Assessorexamen),<br />

Düsseldorf, Germany, 1996<br />

German <strong>Law</strong> School Exam,<br />

University of Göttingen,<br />

Germany, 1992<br />

Admissions<br />

Brussels (associate member)<br />

Frankfurt, Germany<br />

New York


� Novartis in the sale of its medical nutrition and baby food divisions to Nestlé and in its acquisition<br />

of Hexal AG before the <strong>EU</strong> Commission<br />

� CVC Capital Partners, a major private equity firm, in its acquisition of DSI Holding GmbH<br />

� Paramount in its acquisition of DreamWorks before the German Federal Cartel Office<br />

Rankings<br />

� Chambers Global 2012 for <strong>Competition</strong>/European <strong>Law</strong>: Belgium<br />

� Chambers Europe: Europe’s Leading <strong>Law</strong>yers for Business 2011 for <strong>Competition</strong>/European <strong>Law</strong><br />

� The Legal 500 EMEA 2011 for <strong>Competition</strong><br />

� The International Who's Who of <strong>Competition</strong> <strong>Law</strong>yers 2011<br />

� Chambers Global: The World's Leading <strong>Law</strong>yers for Business 2011 for <strong>Competition</strong>/European<br />

<strong>Law</strong><br />

Professional and Community Activities<br />

� Member, American Bar Association<br />

� Member, Studienvereinigung Kartellrecht<br />

Articles<br />

� Silvio Cappellari "Recent Developments in German Antitrust <strong>Law</strong>" The Computer and Internet<br />

<strong>Law</strong>yer, June 2012 (forthcoming)<br />

� Silvio Cappellari "Reverse Payment Settlements in the <strong>EU</strong> - Finding the Right Dosage"<br />

<strong>Competition</strong> <strong>Law</strong> International, November 2011<br />

� Silvio Cappellari "Frankfurter Kommentar zum Kartellrecht" Article 8 ECMR, October 2011<br />

Advisories<br />

� "Recent Developments in German <strong>Competition</strong> <strong>Law</strong>" Jan. 2012<br />

� "N<strong>EU</strong>E ENTWICKLUNGEN IM D<strong>EU</strong>TSCHEN" Jan. 2012<br />

� "Neuere Entwicklungen im deutschen Kartellrecht" Jul. 2011<br />

� "Recent Developments in German <strong>Competition</strong> <strong>Law</strong>" Jul. 2011<br />

� "Neuere Entwicklungen im deutschen Kartellrecht" Jan. 2011<br />

� "Recent Developments in German <strong>Competition</strong> <strong>Law</strong>" Jan. 2011<br />

� "Recent Developments in German <strong>Competition</strong> <strong>Law</strong>" Mar. 2010<br />

Silvio Cappellari<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 2


arnoldporter.com<br />

G. Axel Gutermuth<br />

Counsel<br />

<strong>Arnold</strong> & <strong>Porter</strong> (Brussels) <strong>LLP</strong> is a limited liability partnership organized under the laws of the State of New York that is regulated by the Brussels Bar. It is an affiliate of <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong>, a limited liability partnership organized<br />

under the laws of the District of Columbia, which does not itself practice in Brussels.<br />

G. Axel Gutermuth is a member of the firm's<br />

antitrust/competition group with a focus on a<br />

broad range of competition law issues.<br />

Mr. Gutermuth assists and represents clients in<br />

merger control proceedings before the<br />

European Commission and the German Federal Cartel Office. He has<br />

participated in several second phase German and EC merger<br />

proceedings, including landmark cases such as Tetra Laval/Sidel and<br />

Oracle/PeopleSoft. In many of his cases, Mr. Gutermuth assesses<br />

merger filing requirements in jurisdictions around the world and<br />

coordinates the national filing procedures.<br />

As part of his general antitrust counseling practice, Mr. Gutermuth<br />

regularly advises clients on the compliance of joint ventures and other<br />

cooperation agreements with Articles 101 and 102 of the Treaty on the<br />

Functioning of the European Union (formerly Articles 81 and 82 of the<br />

EC Treaty) and the specific rules on cooperation in distribution,<br />

research and development, technology transfer, and production. He<br />

has particular knowledge of the application of competition law in cases<br />

involving intellectual property rights. Moreover, Mr. Gutermuth has<br />

represented clients in cartel investigations, EC anti-dumping<br />

procedures, State aid procedures, and appeals to Court of Justice of<br />

the European Union. He advises clients on internal compliance<br />

procedures and recently concluded a comprehensive antitrust<br />

compliance review of a client's worldwide business in the energy and<br />

chemical sectors.<br />

Mr. Gutermuth has worked for clients in various industries, including<br />

chemical, energy, life science, healthcare, technology, metals,<br />

tobacco, defense and telecommunications/media.<br />

Representative Matters<br />

� Represent a large technology company in a pending<br />

acquisition before the European Commission.<br />

� Represent client in ongoing cartel investigation by the<br />

European Commission.<br />

� Internal competition compliance review of client’s worldwide<br />

operations in the energy and chemical sectors.<br />

Contact Information<br />

Axel.Gutermuth@aporter.com<br />

tel: +32 (0)2 290 7832<br />

fax: +32 (0)2 290 7899<br />

1, Rue du Marquis -<br />

Markiesstraat, 1<br />

B-1000 Brussels<br />

Practice Areas<br />

Antitrust/<strong>Competition</strong><br />

Education<br />

LLM, New York University<br />

School of <strong>Law</strong>, 1999<br />

German Bar Exam<br />

(Assessorexamen),<br />

Karlsruhe, Germany, 1998<br />

German <strong>Law</strong> School Exam,<br />

University of Heidelberg,<br />

Germany, 1996<br />

Certificate of Political<br />

Sciences, University of Aixen-Provence,<br />

France, 1993<br />

Admissions<br />

Brussels (associate member)<br />

Munich<br />

New York<br />

� Securing <strong>EU</strong> merger clearance for General Electric in its US$ 3<br />

billion acquisition of Dresser, Inc. and coordinating international filings in eight other jurisdictions.


� Representing Bucyrus International, Inc. in merger control proceedings before the <strong>EU</strong><br />

Commission and coordinating filings in several other jurisdictions regarding Caterpillar’s US$ 8.6<br />

billion acquisition of Bucyrus.<br />

� Securing German merger clearance for Finmeccanica SpA’s US$ 5.2 billion acquisition of DRS<br />

Technologies and coordination of international filings.<br />

� Representing German citizens as witnesses in a U.S. cartel damages class action regarding the<br />

taking of witness statements in Germany under the Hague Convention.<br />

� Coordinating international merger filings in Bucyrus International Inc.’s US$ 1.3 billion acquisition<br />

of Terex Corporation’s mining equipment business.<br />

� International merger control advice to General Electric on various transactions, including <strong>EU</strong><br />

merger filings.<br />

� Securing German merger clearance for a US$ 2.9 billion merger of pharmaceutical companies.<br />

� Advice on international merger control issues to Cisco Systems in its acquisitions of Starent<br />

Networks.<br />

� Counseling advice to a major international chemicals company regarding complex cooperation<br />

agreements for $1+ billion investments.<br />

� Participation in the representation before the European Commission and the General Court<br />

(previously, the Court of First Instance) of a major international investment bank regarding the<br />

violation of State aid obligations by an Accession Country.<br />

� Representing a leading German company in an abuse of dominance investigation before the<br />

German Federal Cartel Office.<br />

Rankings<br />

� Chambers Global 2012 for <strong>Competition</strong>/European <strong>Law</strong>: Belgium<br />

Professional and Community Activities<br />

� Mr. Gutermuth is author or co-author of several articles and publications on antitrust issues as<br />

well as a frequent conference speaker. He is a member of the Studienvereinigung Kartellrecht,<br />

the leading association of German speaking antitrust lawyers.<br />

Articles<br />

� G. Axel Gutermuth "Der neue Kartellrechtsrahmen für Forschungs- und<br />

Entwicklungsvereinbarungen" Wirtschaft und Wettbewerb, March 2012<br />

� G. Axel Gutermuth "The Revised <strong>EU</strong> <strong>Competition</strong> Rules for Production and R&D Agreements<br />

Create a More Coherent Framework of Assessment and Provide Better Guidance to Companies"<br />

CPI Antitrust Chronicle, February 2011 (1)<br />

� G. Axel Gutermuth "Revision of the <strong>EU</strong> <strong>Competition</strong> Rules on Cooperation in Research &<br />

Development and Production: Scope for Further Improvement" CPI Antitrust Journal September<br />

2010<br />

� G. Axel Gutermuth "Article 82 Guidance: A Closer Look at the Analytical Framework and the<br />

Paper's Likely Impact on European Enforcement Practice" This article was originally published in<br />

GCP Magazine at www.globalcompetitionpolicy.org, February 2009<br />

G. Axel Gutermuth<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 2


� Claus-Dieter Ehlermann, Sven B. Volcker and G. Axel Gutermuth "Unilateral Effects: The<br />

Enforcement Gap under the Old EC Merger Regulation" World <strong>Competition</strong> (Printed by Kluwer<br />

<strong>Law</strong> International) 2005<br />

� G. Axel Gutermuth, Thomas Mueller and John Ratliff "New European Licensing Rules Require<br />

Fresh Assessment of Existing and New Intellectual Property Licenses" Global Intellectual<br />

Property Asset Management Report, June 2004<br />

� G. Axel Gutermuth "Die <strong>EU</strong>-Fusionskontrolle ist umstritten" Frankfurter Allgemeine Zeitung, Jan.<br />

2003<br />

� G. Axel Gutermuth, Eric Mahr and Thomas Mueller "Navigating the Treacherous Shoals of EC<br />

Merger Clearance" International Financial <strong>Law</strong> Review Supplement, 2002<br />

� G. Axel Gutermuth, Paul von Hehn and Christian Duvernoy "New Regulatory Framework for<br />

Electronic Communications - The European Commission's Legislative Proposals" The European<br />

Antitrust Review, 2000<br />

Presentations<br />

� G. Axel Gutermuth "Standard Essential Patents, Injunctions and Abuse of Dominance", copanelist<br />

with DG <strong>Competition</strong>'s Chief Economist Kai-Uwe Kuehn and Pierre Régibeau at the<br />

Concurrences Journal's conference on "Intellectual Property and Antitrust: Recent Issues", April<br />

25, 2012" Jul. 2012<br />

� G. Axel Gutermuth "Article 102 TF<strong>EU</strong> - Recent Developments" at the GCR Live Third Annual <strong>Law</strong><br />

Leaders Europe, Brussels, November 15, 2011<br />

� G. Axel Gutermuth "New <strong>EU</strong> <strong>Competition</strong> Rules on Research and Development Agreements" at<br />

the Conference of the Global <strong>Competition</strong> <strong>Law</strong> Center, Brussels, February 16, 2011<br />

� G. Axel Gutermuth "The Revised Horizontal Agreement Guidelines" at the IBC Advanced<br />

<strong>Competition</strong> <strong>Law</strong> Conference, Brussels, November 23-24, 2010<br />

� G. Axel Gutermuth "The Reform of the <strong>EU</strong>'s Horizontal Rules" at the GCLC Lunch Talk, Brussels,<br />

June 7, 2010<br />

� G. Axel Gutermuth "IP & Antitrust" ESCP-Europe Business School, Paris, yearly event (2006-<br />

2011)<br />

Advisories<br />

� "Will the Lisbon Treaty Have an Impact on Future <strong>EU</strong> <strong>Competition</strong> Policy?" Dec. 2009<br />

� "Private Enforcement of EC State Aid <strong>Law</strong>--EC's Revamped Notice on the Role of National<br />

Courts" Mar. 2009<br />

� "Germany Limits the Reach of its Merger Control <strong>Law</strong> but Introduces New Foreign Investment<br />

Supervision" Feb. 2009<br />

� "Private Label Brands, "Must-Have" Brands, and Impact on Retailer Buyer Power" Feb. 2009<br />

� "European Commission Endorses A More Economic-Based Approach" Dec. 2008<br />

� "New Notice Clarifies <strong>EU</strong> Commission's Approach to Remedies in Merger Cases" Oct. 2008<br />

Multimedia<br />

G. Axel Gutermuth<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 3


� Tim Frazer and G. Axel Gutermuth. "The <strong>Arnold</strong> & <strong>Porter</strong> eComp KnowHow Series: <strong>Competition</strong><br />

Compliance Auditing Webinar" March 21, 2012.<br />

� G. Axel Gutermuth, Luc Gyselen and Susan Hinchliffe. "WEBCAST: First Half of 2011 in Review:<br />

Developments in European <strong>Competition</strong> <strong>Law</strong> that Every in-house Counsel Should Know" June 30,<br />

2011. (also available as a Podcast)<br />

G. Axel Gutermuth<br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> 4


Tab 4: Practice Overview


<strong>EU</strong> <strong>Competition</strong> <strong>Law</strong> Practice<br />

<strong>EU</strong> <strong>Competition</strong> – An Integrated Practice<br />

The <strong>EU</strong> <strong>Competition</strong> team offers the full range of competition law advice on<br />

mergers g and acquisitions, q , non-transactional representation, p , litigation g and<br />

counseling. We provide representation before EC, UK and other national<br />

competition authorities, as well as in European and national courts. We work<br />

with many companies on competition matters including:<br />

� antitrust issues, ranging from merger control over licensing and co-operative<br />

arrangements to market definition and potential abuse of a dominant position<br />

� distribution, and the establishment of lawful quota schemes and innovative<br />

cross-border compensation arrangements<br />

� services ranging from advice on the application of the law to agreements,<br />

conduct, and corporate strategies<br />

� obtaining gclearances for mergers, g , acquisitions, q , and joint j ventures from the<br />

European Commission and national competition authorities both within the <strong>EU</strong><br />

and internationally<br />

� advice/representation relating to cartel investigations, potential abuses of<br />

dominance, structuring of distribution and licensing agreements, strategic<br />

alliances, state aids, and public procurement issues


Why <strong>Arnold</strong> & <strong>Porter</strong>?<br />

� We are the go-to-firm for antitrust in general, and antitrust in regulated markets working for clients<br />

located globally including in Europe, the Americas, Asia and Africa<br />

� Genuine inside knowledge of and well-connected well connected with the <strong>EU</strong> and Member State antitrust<br />

authorities<br />

� Native Danish/Dutch/English/French/German/Italian speakers<br />

� We are experienced in dealing with a range of industries, in particular:<br />

– Life sciences,<br />

– Fast-moving consumer goods,<br />

– Chemicals,<br />

– Transport & logistics,<br />

– Technology, media and telecommunications, and<br />

– EEnergy.<br />

Representative Matters – Mergers: <strong>EU</strong><br />

� General Electric/ Converteam (Phase 1)<br />

� Caterpillar / Bucyrus (Phase 1)<br />

� Intel / McAfee (Phase 1 with conditions)<br />

� General Electric / Dresser (Phase 1)<br />

� BASF / Cognis (Phase 1 with conditions)<br />

� Syngenta / Negocio Semillas Girasol Monsanto (Phase 2 with conditions)<br />

� Comcast / NBC Universal (Phase 1)<br />

� Schneider Electric / AREVA T&D Distribution activities (Phase 1)<br />

� Alstom Holdings / AREVA T&D Transmission activities (Phase 1)<br />

� Kraft Foods / Cadbury (Phase 1 with conditions)<br />

� Philip Morris International/Papastratos (Phase 1)<br />

� Renesas Technology / NEC Electronics (Phase 1)<br />

� Panasonic / Sanyo (Phase 1 with conditions)<br />

� General Electric /NewsCorp / Disney / Hulu JV (Phase 1)<br />

� Ryanair / Aer Lingus (Phase 2)<br />

� Kraft / Danone Biscuits (Phase 1 with conditions)<br />

� Sea-Invest / EMO-EKOM (Phase 2)


Representative Matters – Cartels: <strong>EU</strong> and <strong>EU</strong> Member States<br />

We are currently representing the following:<br />

�� Major player in the optical disk drive sector in an ongoing <strong>EU</strong> investigation<br />

� Large logistics company in an ongoing <strong>EU</strong> investigation<br />

� Power cable supplier in ongoing US and <strong>EU</strong> investigations<br />

� Private investment fund in an ongoing <strong>EU</strong> investigation<br />

� Manufacturer of automotive electronic components in an ongoing <strong>EU</strong> investigation<br />

� Financial institution in an ongoing <strong>EU</strong> investigation<br />

� Manufacturer of automotive wire harnesses in an ongoing g g <strong>EU</strong> investigation g<br />

� International energy company in a national investigation<br />

� Major supplier of transmission and distribution equipment in one German and two <strong>EU</strong> cases<br />

� Three clients in different investigations before the Belgian competition authority<br />

Representative Matters – Other: <strong>EU</strong><br />

� Litigation<br />

– AREVA in two appeals to the European Court of Justice and to the General Court<br />

against two European Commission decisions in the Gas Insulated Switchgear case<br />

and the Power Transformer case<br />

– European Federation of Pharmaceutical Industries Associations (Intervener in<br />

the European Court of Justice appeal against the AstraZeneca judgment rendered<br />

by the General Court in July 2010)<br />

– Parent companies of the international removals company Team Relocations<br />

in their appeal to the General Court against the European Commission’s decision<br />

to hold jointly and severally liable for the fine<br />

– German witnesses in US private litigation in depositions under the Hague<br />

Convention on the taking of evidence abroad<br />

� State Aid<br />

– Belgian g Government (separate ( p <strong>EU</strong> clearances regarding g g State aid measures for<br />

manufacturers of plasma-derived medicines and for pharmaceutical companies<br />

involved in R&D)<br />

� Counseling/Advisory<br />

– Compliance programmes for numerous companies, including Sasol, in connection<br />

with an international extensive compliance audit, and an international FMCG<br />

manufacturer in connection with annual compliance audits


Representative Clients<br />

� ACAS / ECAS<br />

� Air Products<br />

� Allergan<br />

� AREVA<br />

� Astellas<br />

� AT&T<br />

� BASF<br />

� Bayer MaterialScience<br />

� Boston Scientific<br />

� Bristol-Myers Squibb<br />

� Bucyrus<br />

� Cargolux<br />

� CEPA<br />

� Cisco<br />

� <strong>EU</strong> Commission<br />

� General Electric<br />

� Genzyme<br />

Life Sciences – Representative Matters<br />

� Gilead Sciences<br />

� Intel<br />

� IPC Media<br />

� Ipsen<br />

� Komatsu<br />

� Kraft Foods<br />

� Kubota<br />

� Monsanto<br />

� NovoNordisk<br />

� Overgas<br />

� Pfizer<br />

� Philip Morris International<br />

� Ranbaxy<br />

� Renesas<br />

� RIZIV<br />

� Royal Belgian Shipowners<br />

� Sanyo<br />

� Sasol<br />

� Sea-Invest<br />

� Shire Pharmaceuticals<br />

� Visa<br />

Mergers and acquisitions:<br />

� Representing Boston Scientific in its acquisition of Guidant<br />

Abuse of dominance:<br />

� Representing EFPIA, the European Federation of Pharmaceutical Industries and Associations, as<br />

an intervener before the European Courts in AstraZeneca’s appeal against a European<br />

Commission decision imposing a fine against AstraZeneca for alleged abuses of dominance<br />

Restrictive Practices:<br />

� Representing a pharmaceutical company in a European Commission investigation focusing on<br />

allegations of restrictive agreements regarding the entry of generic competition (“pay-for-delay”)<br />

� Representing a pharmaceutical company in an <strong>EU</strong> Member state investigation into potential<br />

restrictive agreements regarding the entry of generic competition<br />

Compliance, including parallel trade:<br />

� Advising gppharmaceutical companies p regarding g gthe European p Commission’s enforcement ppolicy y<br />

regarding parallel trade of pharmaceutical products<br />

� Advising pharmaceutical companies on various competition compliance matters, such as<br />

distribution strategies and competitor cooperation agreements<br />

Assistance in <strong>EU</strong> Commission’s general competition inquiry into the pharmaceutical sector:<br />

� Assisting several large pharmaceutical companies in the <strong>EU</strong> Commission’s general inquiry into<br />

the pharmaceutical sector


Fast Moving Consumer Goods – Representative Matters<br />

We have deep experience in advising FMCG suppliers on complex competition concerns. For example, we<br />

regularly advise on mergers and acquisitions affecting retail markets and provide advice on issues such as:<br />

competitive intelligence gathering; price recommendations; promotions and price-marked packs; trade<br />

discount schemes; price signalling; hub-and-spoke infringements; trade association activities and supply<br />

chain innovations.<br />

Representative matters in relation to FMCGs include:<br />

� Obtaining clearance for Kraft Foods’ US$19 billion hostile bid for Cadbury PLC from the European Commission<br />

including the negotiation of remedies required to secure Phase I clearance.<br />

� Obtaining clearance for Kraft Foods’ US$7.2 billion acquisition of the biscuit business of Danone from the<br />

European Commission and national competition authorities globally involving the negotiation of divestment<br />

remedies.<br />

� Obtaining clearance for Philip Morris International in relation to the acquisition of Papastratos SA, a transaction<br />

that was cleared without remedies on the basis of complex econometric modelling.<br />

� Providing a detailed compliance policy and online training tool for a large FMCG manufacturer including<br />

preliminary compliance audits and feedback sessions, development of training materials and advising on the<br />

substance of an online training system for employees.<br />

� Providing counselling to a European branded goods manufacturers trade association.<br />

Energy – Representative Matters<br />

We have significant experience in providing competition law advice to suppliers of energy equipment and major energy<br />

companies. Particular challenges arise in this area from the interplay between competition law and sector-specific<br />

regulation g and the shared enforcement powers p of the European p Commission’s <strong>Competition</strong> p and Energy gy departments.<br />

p<br />

Representative matters handled by our attorneys include:<br />

Mergers and acquisitions:<br />

� Securing <strong>EU</strong> merger clearance and coordinating worldwide merger filings for Areva regarding its acquisition of Alstom’s<br />

energy transmission and distribution business and the creation of a joint venture between Areva and Urenco in the uranium<br />

enrichment technology area.<br />

� Coordinating worldwide merger filings regarding the creation of a strategic alliance between GE Energy and Hitachi in the<br />

nuclear energy sector.<br />

� Securing <strong>EU</strong> merger clearance and coordinating worldwide merger filings for GE regarding various acquisitions in the energy<br />

equipment sector.<br />

� Representing Iberdrola in proceedings before the European Commission and national courts in relation to the proposed Gas<br />

Natural/Endesa merger.<br />

� Representing Energias de Portugal (EDP) in its application for annulment of the European Commission’s prohibition of the<br />

EDP/ENI/GDP merger before the General Court.<br />

� Securing <strong>EU</strong> merger clearance in relation to the merger of Austrian energy companies Verbund/EnergieAllianz.<br />

� Obtaining, on behalf of one of the sellers, merger clearance in Germany in relation to the E.ON/Ruhrgas merger and<br />

representing German energy utility companies in several merger control cases in Germany.<br />

� Representing Belgian transmission companies in merger proceedings before the Belgian competition authority.


Energy – Representative Matters (cont.)<br />

Cartels:<br />

� Representing Areva regarding the European Commission’s cartel investigations in the gas insulated switchgear and power<br />

transformer sectors and in the subsequent proceedings before the General Court Court.<br />

� Representing a major Japanese company regarding the European Commission’s cartel investigation in the power cables<br />

sector.<br />

Abuse of dominance:<br />

� Representing Overgas, one of Bulgaria’s largest privately held companies, as a complainant before the European<br />

Commission in abuse of dominance proceedings against the State-owned incumbents in the natural gas area.<br />

� Representing a leading wind turbine manufacturer in an abuse of dominance investigation of the German competition<br />

authority.<br />

Assistance in <strong>EU</strong> Commission’s general competition inquiry into the energy sector:<br />

� Assisting a large network operator in relation to the European Commission’s sector inquiry into the gas and electricity<br />

markets.<br />

� Representing a major gas company in the sector inquiry inquiry.<br />

State aid:<br />

� Representing the Hungarian government in ICSID arbitration proceedings brought by electricity generators Electrabel and<br />

AES, with special focus on stranded costs State aid issues.<br />

� Representing Energie Baden-Württemberg AG (EnBW) before the European Commission and the General Court in a<br />

challenge against the Commission’s authorization of the German CO2 emission trading plan (Case T-387/04).<br />

Compliance audit and advice:<br />

� Conducting an extensive internal competition compliance audit for a multinational company active in oil & gas exploration<br />

and in the area of petrochemical products.<br />

Technology, Media, Telecommunications –<br />

Representative Matters<br />

We have significant experience in advising TMT companies on complex competition concerns, including<br />

mergers and acquisitions and interventions in merger control procedures in the <strong>EU</strong> and in Member States,<br />

standard-setting, licensing, patent enforcement and litigation strategies<br />

Representative matters:<br />

� Securing <strong>EU</strong> merger clearance for Intel regarding its acquisition of McAfee, and coordinating international filings<br />

� Advising a provider of online music on <strong>EU</strong> competition law matters in relation to collecting societies<br />

� Advising one of the Majors in connection with a Commission investigation under Article 102 TF<strong>EU</strong><br />

� Advising one of the Majors regarding interventions in merger control procedures in several jurisdictions<br />

� Coordinating international merger filings for Cisco in its acquisition of Starent Networks<br />

� Representing NBCU in merger filings regarding Comcast’s acquisition of a majority stake in NBCU<br />

� Securing <strong>EU</strong> merger clearance for Siemens in its acquisition of UGS, a major US software developer<br />

� Representing NBCU in German merger proceedings relating to the intended creation of a video‐on‐demand<br />

platform


Chemicals – Representative Matters<br />

We have significant and long-standing experience from advising companies active in the (petro-) chemicals<br />

industry on a broad array of competition law concerns, including joint production, sub-contracting, joint<br />

purchasing and technical cooperation agreements, information exchanges, and merger control matters in the<br />

broadest sense:<br />

Representative matters in the chemical industry include:<br />

� Advising on the lawfulness of minority shareholdings in competing undertakings on behalf of several companies<br />

active in the petrochemical sector;<br />

� Advising on the lawfulness of production joint ventures, exclusive supply arrangements and swap agreements<br />

between several chemical companies;<br />

� Obtaining <strong>EU</strong> merger control approvals for BASF in relation to several acquisitions, most recently that of Cognis,<br />

another large chemical company;<br />

� Advising a large European chemicals company on international joint production / joint venture agreements with<br />

competitors; and<br />

� Advising Monsanto in various merger proceedings before the European Commission and coordinating<br />

international merger filings<br />

Transport & Logistics – Representative Matters<br />

We have significant experience advising companies active in transport and logistics, including shipping<br />

companies, airlines, freight forwarders and stevedoring companies, on matters ranging from international<br />

cartel investigations to <strong>EU</strong> merger control proceedings and cooperation agreements. Representative matters<br />

include:<br />

� Representing Mitsui OSK Lines in obtaining merger control clearance for its acquisition of Nissan Motor Carrier<br />

Company.<br />

� Representing Sea-Invest in connection with its acquisition of a controlling stake in stevedoring company EMO-<br />

EKOM, including in connection with the in-depth investigation by the European Commission under the <strong>EU</strong> Merger<br />

Control Regulation.<br />

� Representing Cargolux in the European Commission investigation into the Air Cargo cartel including the<br />

coordination of Cargolux’s defense in various other jurisdictions.<br />

� Representing several freight forwarding companies in connection with European and national cartel investigations.<br />

� Representing a group of leading liquid bulk shipping companies in relation to the establishment of a pool.<br />

� Representing the European Community Shipowners Association (ECSA) in discussions with the European<br />

Commission concerning the introduction of new guidelines on the application of <strong>EU</strong> competition rules to maritime<br />

transport.


Global<br />

Ranked in Globally, US, <strong>EU</strong>, Belgium<br />

6 lawyers ranked<br />

UK<br />

2 lawyers ranked<br />

Europe<br />

Leading firm in Belgium<br />

Leading firm in UK<br />

Leading firm in Europe<br />

5 lawyers ranked<br />

USA<br />

Top tier firm nationally<br />

Top tier firm in DC (10 years)<br />

Ranked in California<br />

11 lawyers ranked<br />

<strong>EU</strong>/UK/German Recognition<br />

Global Recognition<br />

Bill Baer – World’s Leading <strong>Competition</strong> <strong>Law</strong>yer (2 years)<br />

12 lawyers listed<br />

PLC <strong>Competition</strong> Super League<br />

Ranked #14 Worldwide<br />

Recommended for US, <strong>EU</strong> and Brussels<br />

PLC Which <strong>Law</strong> Firm?<br />

Recommended firm for <strong>EU</strong> and Belgium<br />

Leading ffirm for f US S and Washington DCC<br />

PLC Which <strong>Law</strong>yer?<br />

3 <strong>EU</strong> attorneys<br />

8 US lawyers<br />

Debbie Feinstein - “50 Most Influential Women<br />

<strong>Law</strong>yers in America”<br />

Ranked #1 in antitrust (8 years)<br />

Tier 1 in US<br />

(3 attorneys mentioned)<br />

Ranked in Belgium<br />

(3 attorneys mentioned)<br />

Ranked in UK<br />

(2 attorneys mentioned)<br />

Global<br />

Ranked No. 4 in the World<br />

Global Elite firm<br />

Recommended in Brussels<br />

USA<br />

Elite in Washington DC<br />

Women in Antitrust<br />

3 attorneys listed<br />

Chambers Europe 2011,<br />

<strong>Competition</strong>/European <strong>Law</strong> , BELGIUM<br />

This firm recently strengthened its <strong>EU</strong> competition practice with the recruitment of Annette Schild and Silvio<br />

Cappellari from Shearman & Sterling. The team now includes four German‐qualified partners, making it a perfect fit<br />

ffor clients li from f this hi jjurisdiction. i di i<br />

KEY INDIVIDUALS: Much admired department head Marleen Van Kerckhove is mainly recognised for her merger<br />

control expertise. Highlights include acting for Sanyo on the clearance of its <strong>EU</strong>R5.9 billion sale to Panasonic, which<br />

was the first merger between two major Japanese companies to come before the EC. She also has considerable<br />

experience of the pharma industry. Highly reputed partner Annette Luise Schild, who recently moved across from<br />

Shearman & Sterling, represented Areva in the competition and merger control aspects of the sale of its<br />

transmission and distribution businesses to Alstom and Schneider. Partner Luc Gyselen is praised for his<br />

performance on antitrust cases. He is also involved in state aid matters, recently assisting the Belgian government<br />

with obtaining clearance from the EC in relation to state aid measures for manufacturers of plasma‐derived<br />

medicines. "He knows how the Commission looks at things, the procedures that they use, and also the people who<br />

work there ‐ all of which is extremely helpful for us," say sources. "He also provides excellent practical judgement:<br />

he is not the kind of lawyer who expounds theories that are not ultimately helpful for your business ‐ he really tries<br />

to remove barriers." Partner Silvio Cappellari is recognised for his advice on merger control matters, especially<br />

before the EC, but also at a national level before the German and Italian competition authorities. He also handles<br />

Article 102 cases cases.<br />

<strong>Competition</strong>/European <strong>Law</strong>, <strong>EU</strong>ROPE‐WIDE<br />

<strong>Arnold</strong> & <strong>Porter</strong> received a considerable boost recently, gaining a large share of Shearman & Sterling’s former<br />

practice in Germany, including the well‐known Annette Luise Schild. It has expanded its European team from 11<br />

to 18 lawyers and receives significant praise from clients. It is especially noted for its strength in the<br />

pharmaceutical sector. Merger control highlights include securing competition clearance for Kraft's GBP12 billion<br />

hostile bid for Cadbury and securing Phase 1 clearance of Panasonic’s acquisition of Sanyo. Other key clients<br />

include Philip Morris International and Monsanto.<br />

Sources say: “They are extremely responsive and thoughtful; they take the time to learn and understand our<br />

specific business.” “They have a good cross‐section of lawyers from a number of different jurisdictions so they are<br />

able to give an overview of the region, but we also benefit from their American style, given their roots.” “Unlike a<br />

lot of lawyers, they are prepared to put their heads on the block. They give good practical advice and suggest a<br />

real course of action.”<br />

15


<strong>EU</strong>/UK/German Recognition<br />

EMEA Legal 500 2011, <strong>Competition</strong><br />

<strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> is recommended for ‘“heavy” competition issues including cartel work and merger<br />

issues’, and the team’s ‘availability, friendliness and competence’. It secured <strong>EU</strong> competition clearance<br />

for Kraft Foods’ £12bn hostile bid for Cadbury, and Panasonic’s acquisition of Sanyo. It represented<br />

Areva before the General Court against two European Commission decisions in the gas insulated<br />

switchgear, and power transformer cases, and handles good state aid work. Annette Luise Schild is an<br />

‘extraordinary antitrust lawyer with excellent know‐how and judgement, perfectly connected within the<br />

Commission’. The team also provides German competition law advice, where Silvio Cappellari assists.<br />

Marleen Van Kerckhove is also recommended.<br />

UK Legal 500 2011, <strong>EU</strong> <strong>Competition</strong><br />

<strong>Arnold</strong> & <strong>Porter</strong> (UK) <strong>LLP</strong> has advised on some big‐ticket merger work out of its London office, and is gaining<br />

expertise acting for clients on hostile acquisitions. It acted for Monsanto in the European Commission’s Phase II<br />

investigation of its sale of a business to Syngenta. Tim Frazer is well known for his representation of major<br />

pharmaceuticals companies, and Susan Hinchliffe is also recommended; both are ‘knowledgeable, practical,<br />

excellent to work with, and very responsive’.<br />

<strong>EU</strong>/UK/German Recognition<br />

Chambers 2012, UK / <strong>EU</strong> <strong>Competition</strong><br />

<strong>Arnold</strong> & <strong>Porter</strong> is enjoying a burgeoning reputation and strong praise from market commentators. The team is described<br />

as "knowledgeable and practical" by sources and it offers in‐depth sector expertise in the moving consumer goods, retail,<br />

biotech, telecommunications and pharmaceutical industries. Recent highlights include advising Philip Morris on its<br />

proposed acquisition of Protabaco in Colombia.<br />

KEY INDIVIDUALS: Tim Frazer is "impressively responsive and commercial," according to market sources. He heads the UK<br />

competition practice and advises clients on issues across the full range of competition law. Susan Hinchliffe has been<br />

advising Monsanto in acquiring clearance from the EC to dispose of its global sunflower business to Syngenta.<br />

<strong>Arnold</strong> & <strong>Porter</strong> was named in and achieved second place in The <strong>Law</strong>yer's shortlist for "<strong>Competition</strong>/<br />

Regulatory Team of the Year ."<br />

JUVE 2012, German <strong>Competition</strong><br />

Ranked by JUVE for German competition law as one of very few law firms without a German office.<br />

“Recommended practice in antitrust with a visible presence in the Brussels market, as demonstrated by its work for<br />

BASF and Intel in complicated <strong>EU</strong> merger controls. The depth of its antitrust experience came to the fore in its<br />

representation of various parties in prominent antitrust proceedings last year. This is a team to take seriously,<br />

confirm competitors, who also point to its close ties to the well‐known US practice.”<br />

Strengths: Good contacts in the US and France, established international cooperation.<br />

Recommended lawyers: Annette Luise Schild (“one of the most important antitrust lawyers in Brussels” ‐<br />

competitor), Silvio Cappellari (“very competent and pleasant” ‐ competitor).


Snapshot of the <strong>EU</strong> team<br />

Marleen Van Kerckhove, Partner<br />

Marleen heads up the firm's European competition practice and its Brussels office. Her practice<br />

encompasses advice and representation before <strong>EU</strong> and national antitrust agencies on merger control,<br />

abusive conduct, price fixing and other restrictive practices, as well as litigation before European courts.<br />

She has steered many transactions successfully through <strong>EU</strong> and national merger control reviews across<br />

various industry sectors. In addition, she has advised extensively on the application of <strong>EU</strong> competition law<br />

to the pharmaceutical sector, and on the interplay between antitrust and intellectual property law. Ms.<br />

Van Kerckhove is a frequent speaker at programs and conferences in Europe, Japan and North America.<br />

Silvio Cappellari, Partner<br />

Silvio’s practice focuses on a broad range of issues under European and German competition law.<br />

He has represented clients in high‐profile merger control cases before the European Commission and the<br />

German Federal Cartel Office, including several second phase proceedings. He also regularly advises clients<br />

on the compliance of joint ventures and other cooperation arrangements with Article 101 TF<strong>EU</strong>, as well as<br />

on abuse cases under Article 102 TF<strong>EU</strong>.<br />

Tim Frazer, Partner<br />

Tim has over 25 years experience in competition and antitrust law representing and advising clients in a<br />

range of competition issues including merger, transactional, and conduct cases. He has particular<br />

experience in the Life Sciences industry including advising leading pharmaceutical companies on parallel<br />

trade, abuse, and other conduct issues, and on State aids. He divides his time equally between the firm's<br />

London and Brussels offices.<br />

Snapshot of the <strong>EU</strong> team<br />

Luc Gyselen, Partner<br />

Luc joined <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong> in July 2004 after 20 years of public service at various <strong>EU</strong> institutions,<br />

primarily i il at t th the EEuropean CCommission i i (as ( a member b of f th the LLegal lSService i and d lt later hholding ldi several l senior i<br />

positions in DG COMP). His competition law practice encompasses advice and representation before <strong>EU</strong><br />

and national agencies on merger control, abusive conduct, cartels, other restrictive practices, and state<br />

aids.<br />

Susan Hinchliffe, Partner<br />

Sue advises clients operating in a variety of industry sectors including: pharmaceuticals branded<br />

consumer goods, and tobacco on a broad range of <strong>EU</strong> and UK competition law issues. Her<br />

competition law practice has a particular focus on merger control both in <strong>EU</strong> and UK, however she<br />

also advises on European product regulations applying to a broad range of sectors including food<br />

and chemicals (including registration, evaluation, authorisation and restriction of chemical<br />

substances).<br />

bt )<br />

Annette Schild, Partner<br />

Annette concentrates her practice in merger and acquisition transactions. Having worked in Brussels,<br />

Washington DC, and New York, she has successfully defended numerous companies in investigations of<br />

their proposed mergers by the <strong>EU</strong>, German, and French competition authorities. She has also advised on<br />

numerous other high‐profile matters, including cartel investigations, antitrust complaints, horizontal<br />

and vertical collaborations, commercial arrangements, and intellectual property matters. She regularly<br />

lectures on <strong>EU</strong> competition law issues and is a co‐author of the Munich and the Brussels commentaries<br />

on European and German competition law.


Snapshot of the <strong>EU</strong> team<br />

Contact Information<br />

Stephanie Birmanns, Counsel<br />

Stephanie is a German‐qualified lawyer and has more than a decade of experience advising on a broad<br />

range of matters under German and European antitrust law. She regularly represents clients in merger<br />

control cases before the European p Commission and the German Federal Cartel Office, , including g a number<br />

of complex second phase investigations with and without remedies. Her merger control practice also<br />

includes the assessment of filing obligations in other jurisdictions worldwide and the coordination of<br />

multijurisdictional filings.<br />

Niels Ersbøll, Counsel<br />

Niels is a Danish qualified lawyer and has more than ten years' experience practicing <strong>EU</strong> competition law.<br />

After a short term at the European Commission's Directorate General for <strong>Competition</strong>, and several years<br />

spent practicing in the Brussels‐based <strong>EU</strong> competition law groups of leading Danish and international law<br />

firms, he joined <strong>Arnold</strong> & <strong>Porter</strong> <strong>LLP</strong>'s Brussels office at the beginning of 2004, shortly after the office was<br />

established. He has extensive experience advising on cartels and other restrictive practices, merger<br />

control at <strong>EU</strong> and national level, , and compliance p counseling. g<br />

Axel Gutermuth, Counsel<br />

Axel assists clients in merger control proceedings before the European Commission and the German<br />

Federal Cartel Office. He has participated in several second phase German and EC merger proceedings,<br />

including landmark cases such as Tetra Laval/Sidel and Oracle/PeopleSoft. He regularly advises clients<br />

on the compliance of joint ventures and other cooperation agreements with Articles 101 and 102 of the<br />

Treaty on the Functioning of the European Union and the specific rules on cooperation in distribution,<br />

research and development, technology transfer, and production, as well as in government<br />

investigations.<br />

Stephanie Birmanns, Counsel<br />

Luc Gyselen, Partner<br />

Direct Line: +32 (0)2 290 7816<br />

Direct Line: +32 (0)2 290 7831<br />

EE‐mail: mail: Stephanie Stephanie.Birmanns@aporter.com<br />

Birmanns@aporter com EE‐mail: mail: Luc Luc.Gyselen@aporter.com<br />

Gyselen@aporter com<br />

Silvio Cappellari, Partner<br />

Direct Line: +32 (0)2 290 7815<br />

E‐mail: Silvio.Cappellari@aporter.com<br />

Niels Ersbøll, Counsel<br />

Direct Line: +32 (0)2 290 7829<br />

E‐mail: Niels.Christian.Ersboell@aporter.com<br />

Tim Frazer, Partner<br />

Direct Line: +44 (0)20 7786 6124<br />

E‐mail: Tim.Frazer@aporter.com<br />

Axel Gutermuth, Counsel<br />

Direct Line: +32 (0)2 290 7832<br />

E‐mail: Axel.Gutermuth@aporter.com<br />

Susan Hinchliffe, Partner<br />

Direct Line: +44 (0)20 7786 6122<br />

E‐mail: Susan.Hinchliffe@aporter.com<br />

Annette Schild, Partner<br />

Direct Line: +32 (0)2 290 7814<br />

E‐mail: Annette.Schild@aporter.com<br />

Marleen Van Kerckhove, Partner<br />

Direct Line: +32 (0)2 290 7817<br />

E‐mail: Marleen.VanKerckhove@aporter.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!